Browsing by Keyword : Sodium-glucose cotransporter 2 inhibitors
Showing results 1 to 3 of 3
| Pub Year | | Title | AJOU Author(s) |
| 2022 | | Beneficial effects of dipeptidyl peptidase-4 inhibitors and sodium-glucose cotransporter 2 inhibitors on nonalcoholic fatty liver disease | 김혜진, 이나미 |
| 2023 | | Empagliflozin is associated with lower risk of cardiovascular events and all-cause mortality in routine care in East Asia: Results from the EMPRISE study | 김대중, 하경화 |
| 2022 | | Hepatoprotective effects of gemigliptin and empagliflozin in a murine model of diet-induced non-alcoholic fatty liver disease | 강엽, 김대중, 김혜진, 이관우, 이나미, 전자영, 최성이, 한승진, 허유정 |
1
